The impact of GLP-1 medications on weight loss is undeniable, but emerging research suggests the results may only be temporary. A growing body of evidence shows that when patients stop taking GLP-1 ...

Fractyl Health Inc. (NASDAQ:GUTS) is one of the best biotech penny stocks to buy according to analysts. On December 2, Fractyl Health announced positive six-month results from its open-label REVEAL-1 ...

Though post-apocalyptic stories have become an expectation in the film and TV industry, Vice Gilligan‘s 2025 sci-fi, Pluribus, pushes the boundaries. Set in his favorite setting, Albuquerque, New ...

A potential cure for type 1 diabetes has been identified by scientists in a new mouse study. In an animal study, researchers at Stanford School of Medicine discovered that resetting the immune system ...

A new report based on national prescription data shows weight-loss drug use is rising among kids and teens. GLP-1 medications, like Ozempic and Wegovy, are drugs originally developed to treat diabetes ...

Talk about a lucky charm. Drugs like Ozempic — which mimic the appetite-suppressing GLP-1 hormone the body naturally produces after eating — have been shown to spur weight loss as well as ease knee ...

A study co-led by Indiana University School of Medicine researchers presents a potential new strategy to prevent or slow the progression of Type 1 diabetes by targeting an inflammation-related protein ...

The FDA has freed Amgen’s mysterious early-stage obesity asset from a clinical hold, with the phase 1 study now enrolling participants. The historically tight-lipped Amgen execs remain judicious with ...

Aon researchers found that within two years, improved health outcomes for patients who were taking GLP-1 drugs lowers the growth rate of medical care costs. Aon looked at medical claims data for ...